Dawn Health & Novartis Introduce Cora BC to Support Breast Cancer Patients
Shots:
- Dawn Health & Novartis have launched Cora BC app to offer support to all breast cancer pts & their kin following the development of Ekiva MS & Ekiva PNH. Launch will start in Germany, extending to other markets incl. UK, Canada & Australia
- Cora BC tracks pts health with regular check-ins, intuitive graphs, plus personalized reminders for medication & appointments, empowering them to improve adherence towards treatment
- Cora BC also delivers personalized content to ensure pts access to meaningful information while allowing them to prepare diary entries for productive consultations. App does not provide diagnosis or any medical advice
Ref: PR Newswire | Image: Dawn Health & Novartis
Related News:- Astellas Reports the Health Canada’s Approval of Vyloy (Zolbetuximab) Plus Chemotherapy for Advanced G/GEJ Cancer
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
